We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gene Discovered Can Cause Sudden Cardiac Death

By LabMedica International staff writers
Posted on 22 Mar 2017
Researchers have found that mutations in the gene Cadherin 2 (CDH2) can lead to sudden death among young people and athletes with genetically inherited arrhythmogenic right ventricular cardiomyopathy (ARVC), which predisposes patients to cardiac arrest and is a major cause of unexpected death in seemingly healthy young people.

The discovery is the result of an international collaboration led by a team headed by Bongani Mayosi, professor of cardiology at University of Cape Town (South Africa) and Groote Schuur Hospital (South Africa), along with researchers of Auxologico Institute of Milan (Italy) and University of Pavia (Italy), and McMaster University (Ontario, Canada) and Hamilton Health Sciences (Ontario, Canada).

"This is important news for families who have had a young family member suffer a sudden cardiac death, for them to know a genetic cause has been identified," said Dr. More...
Guillaume Paré, associate professor at McMaster University’s DeGroote School of Medicine, "Our team was happy to contribute to the finding that a mutation in CDH2 is the underlying culprit in a portion of these patients. This will pave the way for preventative interventions and genetic counseling."

Inherited forms of cardiomyopathy often cause sudden cardiac arrest death in young people under the age of 35. In ARVC, heart tissue is replaced by fatty and fibrous tissue. This process encourages the development of cardiac arrhythmias such as tachycardia and ventricular fibrillation, which cause loss of consciousness and cardiac arrest. In the case of ventricular fibrillation, without a ready electrical defibrillation, it causes sudden death in a few minutes.

For 20 years, Prof. Mayosi followed a South African family affected by ARVC that had experienced several cases of juvenile sudden death. Excluding all genetic causes known at the time, the Italian researchers sequenced all the coding regions of the genome in two ill members of the family. The mutation responsible for the disease in the family was narrowed down from more than 13,000 common genetic variants present in the two ill patients.

CDH2 is responsible for the production of Cadherin 2 (N-Cadherin), a key protein for normal adhesion between the cardiac cells. The gene's discovery was validated by finding a second CDH2 mutation in another patient with ARVC from a different family. Also, it was known from previous studies that genetically modified mice without this protein tend to have malignant ventricular arrhythmias and sudden death.

Identifying the gene helps to clarify genetic mechanisms underlying ARVC, and makes early detection of ARVC possible in otherwise unsuspecting people. Often, the diagnostic clinical signs of the disease only become clear after many years. Now, if someone with ARVC is a carrier of a defective CDH2 mutation, other family members who are genetically affected can be quickly identified and preventive strategies initiated immediately.

The study, by Mayosi BM et al, was published March 8, 2017, in the journal Circulation: Cardiovascular Genetics.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.